ADVISORY

Prescription for Dangerous Drugs during the State of Public Health Emergency Per Presidential Proclamation No. 922 Dated 18 March 2020

ADVISORY

Advisory for DDCPEC-MS

The DDCPEC-MS will be temporarily unavailable for the submission of semi-annual report (SAR) on January 2023 due to system enhancement. Full restoration of the system will be announced until further notice. Meanwhile, you may submit your SAR through this email: cs.sar@pdea.gov.ph.

For Mixtures, reports should only be submitted through email: lad@ddb.gov.ph. For those stakeholders who already submitted their reports to legaldivision.ddb@gmail.com, please resend your reports at lad@ddb.gov.ph.

For other concerns, you may email misd.helpdesk@ddb.gov.ph.

ADVISORY

Online Payment

The Dangerous Drugs Board is pleased to announce online payment options available in partnership with the Land Bank of the Philippines.

DDB and PDEA works hand-in-hand with European Parliament

Feb 28, 2023

Undersecretary-Executive Director Earl Saavedra and PDEA Director General Moro Virgilio Lazo met with Members of the European Parliament at the Department of Justice on Friday, February 24. The...

DDB – DEPED launch BKD Youth Camp in Davao

Feb 28, 2023

The Department of Education (DepEd) Davao Del Sur, through its Youth Formation Division, organized the Barkada Kontra Droga (BKD) Youth Camp on February 25-26 2023 at the Marcos P. Saez Elementary...

DDB joins Career Executive Service Board’s 1st Quarter Human Resource Managers Fellowship Meeting and Learning Session for 2023

Feb 20, 2023

Dangerous Drugs Board Undersecretary Earl Saavedra (CESO I) delivered the welcome remarks before the attendees of the First Quarter Human Resource Managers Fellowship Meeting and Learning Session...

DDB gives Financial Support for the Improvement of DOH Region 2 Rehab Center

Feb 17, 2023

Dangerous Drugs Board Assistant Secretary Maria Belen Angelita V. Matibag personally handed out a check worth five million pesos to Dr. Charity I. Canapi of DOH Drug Treatment and Rehabilitation...

Cong. Gomez signs MOA with DDB for the Expansion of Ormoc City’s Community Rehab Center

Feb 17, 2023

Ormoc City Congressman Richard Gomez and Dangerous Drugs Board Executive Director Undersecretary Saavedra signed the Memorandum of Agreement for the Expansion of Ormoc City’s Community Based Drug...

Quezon City Mayor Belmonte and DDB holds a Drug-Free Summit

Feb 17, 2023

Dangerous Drugs Board Executive Director Undersecretary Earl P. Saavedra joined Quezon City Mayor Joy Belmonte and Vice Mayor Gian Sotto in holding the Quezon City Drug-Free Summit on February 2,...

« Older Entries

Next Entries »

Chairman's Corner

Secretary Catalino Salandanan Cuy is the Chairman of the Dangerous Drugs Board. He joined the Administration of President Rodrigo R. Duterte in July 2016 as the Undersecretary for Public Order and later on as the Officer-in-Charge of the Department of Interior and Local Government.

Access Information from the Government

Browse over 69928 requests and 530 government agencies

Profile of Drug Abusers

For 2021, a total of sixty-three (63) treatment and rehabilitation facilities reported to the Treatment and Rehabilitation Admission Information System (TRAIS). Of this, fifty-eight (58) are residential, and five (5) are outpatient.

%

Civil Status: Single

%

Status of employment: Employed

%

Educational attainment: Highschool Level

%

Place of residency: Urban (NCR)

Dangerous Drugs Board Report 2020

The government’s approach to address the country’s drug abuse problem is a balanced and holistic one. Current initiatives are focused on community-based approaches in preventive education and treatment and rehabilitation. See here the efforts of the Dangerous Drugs Board, its partner agencies and organizations in fighting the drug menace.

Philippine Anti-Illegal Drugs Strategy

The Philippine Anti-Illegal Drugs Strategy (PADS) is a cohesive, comprehensive, and balanced strategy aligned with international and regional frameworks on drug prevention and control.

Board Members

The Dangerous Drugs Board is managed by a Board, a multi-disciplinary body composed of 17 members, three of whom are Permanent, 12 are Ex-Officio and two are Regular Members. The President of the Republic of the Philippines decides from among the three Permanent Members who will hold the position of Chairman with the rank of a Secretary.

Permanent Member

Secretary CATALINO S. CUY

Chairman, Dangerous Drugs Board

Permanent Member

Follow us on Social Media

Tweets by DDBgov

75,939

Dangerous Drugs Board

www.facebook.com/DDBgov is the official Facebook page of the Dangerous Drugs Board, Philippines.

Dangerous Drugs Board

2 hours ago

LOOK: The following drugs listed below are included in the List of Dangerous Drug Board Regulation, Series of 2022.[BOARD REGULATION NO. 4 Series of 2022}Isotonitazene is a synthetic opioid with a high potential for abuse and dependence and has potency greater than that of morphine or fentanyl.Source: ddb.gov.ph/wp-content/uploads/2023/01/BOARD-REG-2022-NO.-4.pdf[BOARD REGULATION NO. 5 Series of 2022}Diphenidine is a dissociative anesthetic that has been sold as a designer drug and in combination with other research chemicals, particularly synthetic cannabinoids and stimulants in Japanese herbal incense blends.Source: ddb.gov.ph/wp-content/uploads/2023/01/BOARD-REG-2022-NO.-5.pdf[BOARD REGULATION NO. 6 Series of 2022}Clonazolam is allegedly a potent combination of clonazepam and alprazolam, 2.5 times more potent than Xanax and produces intense sedation and amnesia.Source: ddb.gov.ph/wp-content/uploads/2023/01/BOARD-REG-2022-NO.-6.pdf[BOARD REGULATION NO. 7 Series of 2022}Diclazepam also known as chlorodiazepam and 2'-chlorodiazepam, is a benzodiazepine and functional analog of diazapam which is not currently approved for use as a medication but rather sold as an unscheduled substance.Source: ddb.gov.ph/wp-content/uploads/2023/01/BOARD-REG-2022-NO.-7.pdf[BOARD REGULATION NO. 8 Series of 2022}Flubromazolam is triazolobenzodiazepine, a benzodiazepine analog that shares characteristics of the commonly prescribed benzodiazepine. One unique element of this "designer" benzo is its potency. Flubromazolam has produced life-threatening side effectSource: s in individuals.Source: ddb.gov.ph/wp-content/uploads/2023/01/BOARD-REG-2022-NO.-8.pdf ... See MoreSee Less

Photo

View on Facebook

Dangerous Drugs Board

7 hours ago

Please be notified that, due to the agency's ongoing streamlining efforts, the Dangerous Drug Board will temporarily halt accepting requests for drafting, processing, assistance, and/or representation of petitions for voluntary submission and compulsory confinement until further notice. ... See MoreSee Less

Photo

View on Facebook

Dangerous Drugs Board

24 hours ago

DDB@50: United Towards a Healthy, Safe and Productive SocietyAs DDB continues to celebrate its Golden Anniversary, we honor our loyal employees for their years of dedication and hard work. #DDB@50 #DangerousDrugsBoard ... See MoreSee Less

Photo

View on Facebook

Dangerous Drugs Board

2 days ago

Shabu and marijuana are illegal substances that are most frequently abused based on the 2021 Treatment and Rehabilitation Admission Information System (TRAIS) reports from a total of 63 treatment and rehabilitation facilities.Ninety one percent (91.80%) of the admissions were for "shabu," and 26.29% were for marijuana.The third most popular prescription is benzodiazepines, which are sedative drugs that treat anxiety, sleeplessness, seizures, and some mental health issues associated to Covid 19 as well. Yet, "LSD," which was predicted to be a new drug by 2020, came in at number 11 this reporting year.Read more: ddb.gov.ph/2021-statistical-analysis/ ... See MoreSee Less

Photo

View on Facebook

Dangerous Drugs Board

2 days ago

The National Youth Commission reaffirmed its commitment to pursue the deliverables for the youth sector under the Philippine Anti-Illegal Drugs Strategy. A Memorandum of Agreement was signed extending the validity of the utilization of the funding support released by the DDB to the Commission. We look forward to NYC’s output and policy recommendations in further institutionalizing the Special Drug Education Centers (SDECs) and its operability mechanisms. ... See MoreSee Less

Photo

View on Facebook

Follow us on Social Media

DangerousDrugsBoard

Development, Drug Treatment and Rehabilitation inlcuding Research.

DangerousDrugsBoard

The annual high-level discussion provides a platform for significant international and regional cooperation highlighting important aspects of the ASEAN Work Plan in Securing Communities Against Illicit Drugs. Concerns range from Law Enforcement, Preventive Education, Altnernative

DangerousDrugsBoard

Officials from the Dangerous Drugs Board, Philippine Drug Enforcement Agency, Department of Health and the ASEAN Training Center for Preventive Drug Education constitute the Philippine Delegation to the 43rd ASEAN Senior Officials Meeting on Drug Matters in Kuala Lumpur, Malaysia https://t.co/cBS9FZcDoB

Reach Us



3rd Floor DDB-PDEA Bldg., National Government Center,
NIA Rd, Diliman, Quezon City, Metro Manila 1100



(02) 8929-4544
(02) 8929-1753



info@ddb.gov.ph

ADVISORY

ADVISORY

Advisory for DDCPEC-MS

ADVISORY

DDB and PDEA works hand-in-hand with European Parliament

DDB – DEPED launch BKD Youth Camp in Davao

DDB joins Career Executive Service Board’s 1st Quarter Human Resource Managers Fellowship Meeting and Learning Session for 2023

DDB gives Financial Support for the Improvement of DOH Region 2 Rehab Center

Cong. Gomez signs MOA with DDB for the Expansion of Ormoc City’s Community Rehab Center

Quezon City Mayor Belmonte and DDB holds a Drug-Free Summit

Chairman's Corner

Access Information from the Government